- Jens Eckstein
- Cambridge, MA
- Admin Support - Janet Mastrocola
- Alios BioPharma, Thrasos Therapeutics
Dr. Eckstein comes to SR One from TVM Capital where he was a Venture Partner, Entrepreneur-in-Residence and appointed CEO and President of SelectX Pharmaceuticals. Prior to that, he was a General Partner in TVMs Boston life sciences practice where he focused on earlier-stage investments. He was a member of the Board of Directors for CoNCERT Pharmaceuticals, Enanta Pharmaceuticals, SelectX Pharmaceuticals, Rapid Micro Biosystems, Anchor Therapeutics, and an Advisor to Sirtris Pharmaceuticals.
Jens was the founder of Akikoa Pharmaceuticals, a biotechnology start-up company focusing on hearing loss, and North Haven Systems, a life science IT company. Prior to joining TVM Capital, Jens led drug discovery programs at Enanta Pharmaceuticals, Inc. and Mitotix, Inc.
He is the author of more than 25 scientific publications and holds several issued and pending patents. He was managing editor of Frontiers in Biosciences Current Topics in Lead Discovery and served as an editorial board advisor for IDrugs. Jens is an Advisor to the Alzheimer Research Forum (ARF), founding member of the Cure Dystonia Initiative Advisory Council (CDIAC) and a Kauffman Fellow.